the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Consistency vital for Sze Fei-Izzuddin to secure titles as professionals – Boon Heong

FORMER national shuttler Tan Boon Heong believes that only a consistent performance embodied by the Goh Sze Fei-Nur Izzuddin Mohd Rumsani pairing will be key to success for the pair after starting to move professionally.

Boon Heong, part of a successful men’s doubles pair (Koo Kien Keat) who tpped the world ranking, said through consistency in recording positive results at various tournaments in addition to high self-discipline, both of them do not need to worry about their ‘adventure’ as professional players.

“It is actually a positive move. Now there is someone who can help them to participate in any tournament and they are also more free to practice. They also now have to rely on each other after no longer with the Badminton Association of Malaysia (BAM).

“Moving professionally requires a sponsor, so if there is a result, there is consistency, other things will not be a problem for them,” he said when met at the Li Ning Three Saga Cup tournament here today.

Sze Fei-Nur Izzuddin left BAM and moved professionally starting Sept 1.

Before leaving the governing body, the pair ranked 12th in the world, ended their tenure with BAM with sweet memories by winning the Japan Open tournament in August.

Earlier, the pair booked their first final as professionals by beating Indonesian pair Shohibul Fikri-Daniel Marthin 21-14, 24-22 in the semi-finals of the 2024 China Open.

The semifinal action took place today at the Changzhou Olympic Games Center, China.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings